{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:32:20Z","timestamp":1792801940890,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT094085MA"],"award-info":[{"award-number":["WT094085MA"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jconrel.2020.03.026","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T17:02:42Z","timestamp":1584637362000},"page":"177-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"special_numbering":"C","title":["Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery"],"prefix":"10.1016","volume":"322","author":[{"given":"Aaron J.","family":"Courtenay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"McAlister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mael\u00edosa T.C.","family":"McCrudden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etgar","family":"Levy-Nissenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nava","family":"Shterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Carmel","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen O.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0766-4147","authenticated-orcid":false,"given":"Ryan F.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.03.026_bb0005","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.jconrel.2020.03.026_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k5354","article-title":"Treatment resistant depression: what are the options?","author":"McLachlan","year":"2018","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jconrel.2020.03.026_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(19)30394-3","article-title":"Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval","author":"Turner","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jconrel.2020.03.026_bb0020","author":"Janssen Announces U.S"},{"issue":"1","key":"10.1016\/j.jconrel.2020.03.026_bb0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2018.07.009","article-title":"Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride","volume":"285","author":"Migdadi","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.03.026_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111547","article-title":"Hydrogel-forming microneedles prepared from \u201csuper swelling\u201d polymers combined with lyophilised wafers for transdermal drug delivery","author":"Donnelly","year":"2014","journal-title":"PLoSONE."},{"issue":"8","key":"10.1016\/j.jconrel.2020.03.026_bb0035","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1021\/acs.molpharmaceut.8b00544","article-title":"Microneedle-mediated transdermal delivery of bevacizumab","volume":"15","author":"Courtenay","year":"2018","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2020.03.026_bb0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11095-010-0169-8","article-title":"Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique","volume":"28","author":"Donnelly","year":"2011","journal-title":"Pharm. Res."},{"issue":"23","key":"10.1016\/j.jconrel.2020.03.026_bb0045","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1002\/adfm.201200864","article-title":"Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery","volume":"22","author":"Donnelly","year":"2012","journal-title":"Adv. Funct. Mater."},{"issue":"1-2","key":"10.1016\/j.jconrel.2020.03.026_bb0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test nethods for microneedle insertion studies","author":"Larraneta","year":"2014","journal-title":"Int. J. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920301784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920301784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:27:11Z","timestamp":1790184431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920301784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":10,"alternative-id":["S0168365920301784"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.03.026","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}